Stock Chart

SRRK

$46.61 +5.12%
Score: 56.4 HOLD
LEAPs: SELL $55
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $55
Premium: $8.60
Expiry: Jan 15, 2027
Target: $50
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $42.11 - $52.97 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.56
Vol: 0.98x (vs SPY: 1.0x | vs QQQ: 1.1x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About SRRK - Scholar Rock Holding Corporation Common Stock

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Key Statistics

Market Cap $5B

This SRRK stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track SRRK's price movements with trendlines, gamma walls, and key support/resistance levels.